PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Mepartricin→

Mepartricin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
11121-32-7
Molecular formula
C119H174N4O38
Molecular weight
2268.7 g/mol
Drug class
Polyene macrolide antibioticantifungal and antiprotozoal agent
Mechanism of action
A polyene macrolide antibiotic complex derived from Streptomyces aureofaciens. Like other polyenes, it is associated with interaction with sterol-containing biological membranes, although the exact composition and detailed mechanism of mepartricin are not fully characterised.
Indications / reported uses
  • Used in some countries for selected urological indications, including benign prostatic hyperplasia, and historically for antifungal or antiprotozoal purposes; indications and availability vary by jurisdiction.

Sources: https://www.ncbi.nlm.nih.gov/mesh/?term=D008613 · https://meshb.nlm.nih.gov/record/ui?dcmsLinks=true&ui=D008613 · https://www.ncbi.nlm.nih.gov/mesh/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Mepartricin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Mepartricin Permitted Daily Exposure (PDE) report (the Mepartricin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Mepartricin Occupational Exposure Limit (OEL) report (the Mepartricin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.